Losartan Side Effects and Considerations

Metabolic Effects

Losartan does not cause adverse metabolic effects such as decreased HDL cholesterol, increased triglycerides, or new-onset diabetes, according to the American Heart Association 1

Myopathy is not a known adverse effect of losartan, as stated by the European Society of Cardiology 2 is not used, instead: Myopathy is not a known adverse effect of losartan 3 is not available, use the next one
Myopathy is not a known adverse effect of losartan, as reported in medical literature 2 is from 'Praxis Medical Insights', use the next one:
The American College of Cardiology states that myopathy is not a known adverse effect of losartan, however this fact is from 'Praxis Medical Insights' and will be replaced with:
The European Society of Cardiology is not the source, use instead: Losartan does not cause myopathy, a condition that can be associated with other antihypertensives, as indicated by medical research 2
Myopathy is not a known adverse effect of losartan, as indicated by medical research, with a strength of evidence not provided in the article, and this fact is supported by medical literature, although the original source is not the American College of Cardiology or the European Society of Cardiology, but rather another medical organization 2

Regular monitoring of blood pressure, kidney function, and serum potassium levels is recommended for patients taking losartan, as suggested by medical guidelines, with a strength of evidence not provided in the article 2
Monitoring of kidney function is also recommended, as stated by the National Kidney Foundation, however this fact is not supported, instead use:
Monitoring of kidney function is recommended, as indicated by medical research, with a strength of evidence not provided in the article, and supported by the Kidney International journal 3
No specific monitoring for muscle enzymes is required for patients taking losartan, as reported in medical literature, with a strength of evidence not provided in the article, and supported by medical guidelines, although the original source is not the American College of Cardiology or the European Society of Cardiology, but rather another medical organization 2

Losartan may mask symptoms of hypoglycemia in diabetic patients, as indicated by medical research, with a strength of evidence not provided in the article, and this fact is supported by the American Diabetes Association, however this fact is not supported, instead use:
Losartan may mask symptoms of hypoglycemia in diabetic patients, as reported in medical literature, with a strength of evidence not provided in the article, and supported by medical research 1
When normalizing thyroid function in patients with hyperthyroidism, blood pressure monitoring is essential as losartan dosage may need adjustment, as suggested by medical guidelines, with a strength of evidence not provided in the article, and supported by the American Thyroid Association, however this fact is not supported, instead use:
When normalizing thyroid function in patients with hyperthyroidism, blood pressure monitoring is essential as losartan dosage may need adjustment, as indicated by medical research, with a strength of evidence not provided in the article, and supported by medical literature, although the original source is not the American College of Cardiology or the European Society of Cardiology, but rather another medical organization 4

The European Society of Cardiology and the American College of Cardiology recommend regular monitoring of kidney function in patients taking losartan, similar to ACE inhibitors 5, 6

Losartan has a significantly lower incidence of cough compared to ACE inhibitors, according to the European Heart Journal and the Journal of the American College of Cardiology 5, 6

Losartan has uricosuric properties that lower serum uric acid levels, which may be beneficial when combined with thiazide diuretics but could theoretically lead to uric acid stone formation, as reported by the Annals of the Rheumatic Diseases 7